HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

46.460

-1.740-3.61%

Volume:12.04M

Turnover:568.78M

Market Cap:308.36B

PE:33.78

High:49.000

Open:48.300

Low:46.040

Close:48.200

52wk High:94.869

52wk Low:46.040

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:1.19

T/O Rate:4.67%

Dividend:0.23

Dividend Rate:0.50%

EPS(LYR):1.375

ROE:12.46%

ROA:7.02%

PB:4.10

PE(LYR):33.78

PS:8.45

Loading ...

Overview Company News Filings

Hengrui Pharma Secures NMPA Approval for Adebrelimab as China’s First Domestic Peri-operative PD-L1 Therapy for Resectable NSCLC

Bulletin Express

Hengrui Pharma secures NMPA green light for China’s first 0.1% water-free cyclosporine eye-drop

Bulletin Express

Hengrui Pharma's Adebrelimab Injection Gains Approval for Additional NSCLC Perioperative Indication

Jiangsu Hengrui Pharmaceuticals - Subsidiary Received Notification from Nmpa Approving New Indication for Adebrelimab Injection

THOMSON REUTERS

AH Share Premium and Deviation Rankings as of June 24th Close

Movement Alert｜Hengrui Medicine Rises 3.47% in Regular Trading, First Self-Developed Innovative Drug Marketing Application Accepted by EMA

Hengrui Pharma Withdraws Registration Application for Emaxitinib Ointment

Hong Kong Stocks Surge: Innovative Drug Sector Rallies on Regulatory Report and New Foreign Investment Policies

European Drug Regulator Accepts Hengrui Pharma's Marketing Application for Revulutamide Tablets

MT Newswires Live

Movement Alert｜Hengrui Medicine Rises 3.73% in Regular Trading, First Self-Developed Innovative Drug Marketing Application Accepted by EMA

Hengrui Pharma's Novel Drug Application for Rezvilutamide Accepted by European Regulator

AH Premium and Deviation Data for June 22

Movement Alert｜Hengrui Medicine Falls 3.02% in Regular Trading, Broad Pharma Sector Sell-Off Amid Geopolitical Headwinds

AH Share Premium and Deviation Rankings as of June 18th

Movement Alert｜Hengrui Medicine Rises 3.02% in Regular Trading, Multiple Drug Approvals and Institutional Buying Boost Sentiment

Schroders Increases Stake in Hengrui Pharma by 948,800 Shares at HK$54.54 Per Share

Hengrui Pharma repurchases 120,000 A shares for ESOP; treasury stock rises to 8.31 million

Bulletin Express

Hengrui Pharma Executes Share Buyback on June 17

China Greenlights Clinical Trials for Two Hengrui Pharma Drugs, Approves Another Indication for Breast Cancer Drug

MT Newswires Live

Jiangsu Hengrui Pharmaceuticals - Received Notice From Nmpa New Indication for Dalpiciclib Isethionate Tablets, Cdk4/6 Inhibitor Approved

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/01276/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":46.46,"timestamp":1787558901004,"preClose":48.2,"halted":0,"volume":12040260,"delay":0,"changeRate":-0.0360995850622407,"floatShares":258000000,"shares":6637000000,"eps":1.3753627686086425,"marketStatus":"Closed","change":-1.74,"latestTime":"08-24 16:08:21","open":48.3,"high":49,"low":46.04,"amount":568780892,"amplitude":0.061411,"askPrice":46.46,"askSize":29000,"bidPrice":46.44,"bidSize":200,"shortable":3,"etf":0,"ttmEps":1.3563524577984671,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787621400000},"marketStatusCode":5,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":48.2,"dividendRate":0.005023,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"volumeRatio":1.19177,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":46.76,"timestamp":1787554800000,"preClose":47.74,"halted":0,"volume":86002300,"delay":0,"premium":"-14.75"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.375363,"volumeRatio":1.19177,"shares":6637000000,"dividePrice":0.233112,"high":49,"amplitude":0.061411,"preClose":48.2,"low":46.04,"week52Low":46.04,"pbRate":"4.10","psRate":"8.45","week52High":94.869,"institutionHeld":0,"latestPrice":46.46,"committee":-0.986301,"eps":1.3753627686086425,"divideRate":0.005017,"volume":12040260,"delay":0,"ttmEps":1.3563524577984671,"open":48.3,"prevYearClose":71.002,"prevWeekClose":48.2,"prevMonthClose":57.1,"prevQuarterClose":57.85,"fiveDayClose":53.7,"twentyDayClose":57.05,"sixtyDayClose":58.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761615000000,"name":null,"time":"","dateTimestamp":1761580800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-08-21","current":33.851605,"percent":0.064935,"low":37.44534,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"high":65.582363,"avg":51.795451,"sd":7.046662,"marketCap":366558497066.13},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13}],"updateTime":1787528660765},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1141236799","title":"Hengrui Pharma Secures NMPA Approval for Adebrelimab as China’s First Domestic Peri-operative PD-L1 Therapy for Resectable NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1141236799","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141236799?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:04","pubTimestamp":1782392687,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma, 01276.HK) announced that its wholly owned subsidiary, Shanghai Suncadia Medicine Co., Ltd., has received National Medical Products...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116136614","title":"Hengrui Pharma secures NMPA green light for China’s first 0.1% water-free cyclosporine eye-drop","url":"https://stock-news.laohu8.com/highlight/detail?id=1116136614","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116136614?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:04","pubTimestamp":1782392677,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) announced that its subsidiary Chengdu Suncadia Medicine has received National Medical Products Administration (NMPA) approval to launch...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137621027","title":"Hengrui Pharma's Adebrelimab Injection Gains Approval for Additional NSCLC Perioperative Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1137621027","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137621027?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:59","pubTimestamp":1782392348,"startTime":"0","endTime":"0","summary":"Hengrui Pharma has announced that its subsidiary, Shanghai Shengdi Pharmaceutical Co., Ltd., recently received notification from the National Medical Products Administration. The notification...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0405327148.USD","LU0359201885.HKD","LU1820825898.SGD","LU2289578879.USD","LU2580892862.HKD","01276","LU2488822045.USD","LU2097828474.EUR","LU2097828631.EUR","LU2097828714.EUR","BK0239","BK0028","LU1146622755.USD","LU0359202008.SGD","LU2097828805.USD","LU1655091616.SGD","LU2148510915.USD","LU2580892789.USD","BK0188","LU1328615791.USD","LU1781817850.SGD","BK0012","LU2543165471.USD","600276","BK0196","LU2097828557.USD","LU0359201612.USD","LU2495084118.USD","BK1191","LU0405327494.USD","LU1969619763.USD","BK0060","LU2328871848.SGD","LU1023057109.AUD","LU1997245177.USD","LU1580142542.USD","BK0183","LU1997244956.HKD","LU1255011170.USD","LU1997245094.SGD","LU1064131003.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646082968","title":"Jiangsu Hengrui Pharmaceuticals - Subsidiary Received Notification from Nmpa Approving New Indication for Adebrelimab Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2646082968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646082968?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:48","pubTimestamp":1782391701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42W15H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0012","LU2097828631.EUR","600276","LU0359201885.HKD","LU1820825898.SGD","LU2289578879.USD","LU2328871848.SGD","LU2543165471.USD","LU1781817850.SGD","LU0359202008.SGD","LU1997245177.USD","BK0239","LU1997245094.SGD","LU2488822045.USD","LU2097828805.USD","LU1255011170.USD","LU1064131003.USD","LU2097828714.EUR","BK0188","BK0060","LU2148510915.USD","LU0359201612.USD","BK0196","LU1580142542.USD","LU0405327148.USD","LU0405327494.USD","LU2097828474.EUR","01276","BK0028","LU1328615791.USD","BK0183","LU2580892789.USD","LU1997244956.HKD","LU2580892862.HKD","LU2097828557.USD","LU1023057109.AUD","LU1655091616.SGD","BK1191","LU1064130708.USD","LU1969619763.USD","LU1146622755.USD","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162114379","title":"AH Share Premium and Deviation Rankings as of June 24th Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1162114379","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162114379?lang=en_us&edition=fundamental","pubTime":"2026-06-24 16:24","pubTimestamp":1782289475,"startTime":"0","endTime":"0","summary":"As of the market close on June 24th, the top three stocks with the highest AH share premiums were NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and SINOPEC SSC (01033), with premiums of 881.82%,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0737861772.HKD","02218","LU1023057109.AUD","BK1198","LU0516422440.USD","BK1576","LU1794554557.SGD","01088","BK1197","HK0000252152.HKD","LU0588546209.SGD","LU0048580855.USD","LU0516422366.SGD","LU1282649141.HKD","BK1594","03143","BK1537","LU0823040885.USD","03750","LU0244354667.USD","LU1769817179.HKD","LU0049853897.USD","LU1048596156.SGD","LU0117841782.USD","IE00BZ08YT58.USD","LU0287142896.SGD","LU0320764599.SGD","BK1506","LU2778985437.USD","LU0228659784.USD","SG9999002463.SGD","IE00BGV7N243.SGD","LU0328353924.USD","SG9999004220.SGD","LU0463099449.HKD","LU0455707207.USD","IE0032431581.USD","LU0348814723.USD","LU0469268626.HKD","LU2177674079.SGD","BK1240","01057","LU0359202008.SGD","LU0061477393.USD","LU1961090484.USD","BK1562","LU0329678337.USD","BK1170","BK1510","BK1193","LU0345780521.USD","BK1515","LU2097828805.USD","BK1530","SG9999011746.SGD","02691","LU1226287529.USD","SG9999002828.SGD","LU2097828631.EUR","LU2045819591.USD","LU0164939612.USD","LU0211977185.USD","BK1546","LU1880383440.USD","BK1154","LU1282649810.SGD","LU2476274720.SGD","IE00BVYPNP33.GBP","BK1105","LU1688375341.USD","00588","LU1993786604.SGD","LU1366334578.USD","BK1578","HK0000252160.HKD","03200","IE00BMCWC346.EUR","LU0039217434.USD","LU1242518931.SGD","LU0543330483.HKD","LU1244550494.USD","IE00B29SXG58.USD","LU0797268264.HKD","LU1960683339.HKD","LU0348827113.USD","SG9999001226.SGD","BK1163","LU1719994722.HKD","LU1770034418.SGD","LU0737861699.HKD","BK1237","BK1551","LU0880133367.SGD","LU0054450605.USD","BK1149","LU1831875114.USD","IE00BZ08YS42.EUR","02899","LU0449515922.USD","LU0384037296.USD","LU0314109678.HKD","BK1178","LU0181495838.USD","LU0345780281.USD","LU0214875030.USD","HK0000306685.HKD","LU0572944931.SGD","BK1505","BK1554","LU0164865239.USD","LU0791590937.USD","LU1064131342.USD","LU2543165471.USD","LU1880383366.USD","LU2125910500.SGD","LU2264538146.SGD","LU0082770016.SGD","LU1813983027.USD","00916","LU1224709979.USD","LU1303224171.USD","BK1140","HK0000352382.USD","LU0307460666.USD","HK0000320264.USD","00991","LU0096374516.USD","LU0067412154.USD","01898","LU0231483743.USD","LU0791591158.USD","BK1191","LU1008478684.HKD","BK1513","LU0254981946.USD","LU0266512127.USD","LU0052750758.USD","LU0051755006.USD","LU0456854461.SGD","LU1988902786.USD","LU1808992512.USD","LU0531970944.HKD","LU0327786744.USD","IE0031814852.USD","BK1526","00168","LU0029875118.USD","LU0979878070.USD","LU0648948544.HKD","LU0516422952.EUR","HK0000352291.HKD","IE0034224299.USD","LU0886674414.USD","LU0607220059.USD","LU2226246903.HKD","LU0106959298.USD","IE00BZ08YR35.GBP","LU0072913022.USD","LU0531971595.HKD","LU0163747925.USD","01081","LU2476274308.USD","LU0823426480.USD","03296","LU1152091168.USD","02476","LU1188198961.HKD","LU0672654166.SGD","LU0488056044.USD","LU1046422090.SGD","03678","LU0823426308.USD","BK1514","BK1507","LU1171460220.USD","00956","BK1604","BK1205","LU0348825331.USD","LU0326950275.SGD","02208","LU1282648689.USD","BK1125","BK1231","BK1223","LU0165289439.USD","SG9999014674.SGD","06869","01108","LU0266512473.USD","LU0128522157.USD","LU0634319403.HKD","BK1180","LU0516423091.SGD","LU0173614495.USD","LU0620787316.HKD","LU0828237510.HKD","LU0164880469.USD","01033","IE00B3M56506.USD","LU0561508036.HKD","01276","BK1166","LU1769817096.USD","IE00B031HY20.USD","LU2242644610.SGD","LU0431992006.USD","LU2039709279.SGD","IE00BVYPNQ40.USD","LU3063872942.SGD","IE00B031J352.USD","02359","LU1504937902.USD","LU0082770016.USD","BK1147","LU0456846285.SGD","HK0000500386.USD","LU2399975544.HKD","LU0862451753.SGD","LU1807302812.USD","LU1244550221.USD","BK1583","LU0543330566.HKD","02338","LU0449509016.USD","IE00BGHQDM52.EUR","HK0001040168.HKD","LU0890818403.SGD","LU1152091754.HKD","BK1564","IE0008369823.USD","03328","02607","LU0828237940.HKD","LU2097828474.EUR","IE00B5MMRT66.SGD","00553","HK0000306701.USD","SG9999001093.SGD","LU0329678170.USD","LU0228367735.SGD","LU2008162690.USD","LU0918141887.USD","HK0000320223.HKD","BK1503","LU2294711473.HKD","LU2097828557.USD","LU0348816934.USD","LU0348767384.USD","BK1110","LU0589944569.HKD","LU0417516738.SGD","BK1183","LU1366334651.USD","LU0502904849.HKD","LU1242518857.USD","LU0229945570.USD","LU0821914370.USD","LU0315179316.USD","IE00B543WZ88.USD","BK1171","LU2279858448.HKD","IE00BYV24P56.USD","LU0456827905.SGD","LU1115378108.SGD","BK1141","LU0501845795.SGD","LU0140636845.USD","LU0871576103.HKD","LU0417516902.SGD","01330","LU0348788117.USD","LU1675838814.USD","LU0540923850.HKD","LU2097828714.EUR","LU1244550577.SGD","BK1544","HK0001040143.USD","LU0149721374.USD","03986","00042","BK1144","SG9999006597.SGD","LU0640798160.USD","LU0593848301.USD","LU0868486357.SGD","LU1481107354.HKD","BK1592","BK1202","LU0359201612.USD","06613","03968","LU1251922891.USD","LU0359201885.HKD","01812","BK1610","BK1116","LU0149534421.HKD","IE0008368742.USD","BK1558","LU0106252389.USD","LU0370786039.SGD","LU0043850808.USD","LU0320764755.SGD","LU1211504680.USD","BK1522","IE00BF5LJ272.USD","LU1105468828.SGD","02465","159982","EWH","LU0918141705.HKD","LU1328277881.USD","LU0348735423.USD","LU0708995583.HKD","LU0348766576.USD","LU0516423174.USD","BK1521","LU1282649067.USD","399300","BK1560","LU1720050803.USD","LU0348805143.USD","00719","BK1523","BK1538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192624255","title":"Movement Alert｜Hengrui Medicine Rises 3.47% in Regular Trading, First Self-Developed Innovative Drug Marketing Application Accepted by EMA","url":"https://stock-news.laohu8.com/highlight/detail?id=1192624255","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192624255?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:44","pubTimestamp":1782265476,"startTime":"0","endTime":"0","summary":"On June 24, Hengrui Medicine (01276.HK) rose 3.47% in regular trading, trading at HK$57.9/share, with turnover of HK$26.10 million. The stock continued its upward momentum following a 3.73% gain in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114089161","title":"Hengrui Pharma Withdraws Registration Application for Emaxitinib Ointment","url":"https://stock-news.laohu8.com/highlight/detail?id=1114089161","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114089161?lang=en_us&edition=fundamental","pubTime":"2026-06-23 19:34","pubTimestamp":1782214475,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (ASX: 01276) has announced that it recently received a \"Notice of Termination of Drug Registration Application\" from the National Medical Products Administration (NMPA), agreeing to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997245094.SGD","BK0028","LU2580892862.HKD","BK0060","LU1064131003.USD","LU1023057109.AUD","LU0359201885.HKD","LU2580892789.USD","LU2097828631.EUR","LU1969619763.USD","LU2148510915.USD","BK0012","LU0405327494.USD","LU2488822045.USD","LU1781817850.SGD","LU0359201612.USD","BK1191","BK0239","LU2495084118.USD","01276","LU1655091616.SGD","LU2097828557.USD","LU2289578879.USD","LU1146622755.USD","BK0196","LU0359202008.SGD","LU1255011170.USD","LU2543165471.USD","LU1820825898.SGD","BK0188","LU2097828714.EUR","LU1328615791.USD","600276","LU1997244956.HKD","LU2097828474.EUR","LU2097828805.USD","LU1064130708.USD","LU0405327148.USD","LU1580142542.USD","LU1997245177.USD","LU2328871848.SGD","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100407015","title":"Hong Kong Stocks Surge: Innovative Drug Sector Rallies on Regulatory Report and New Foreign Investment Policies","url":"https://stock-news.laohu8.com/highlight/detail?id=1100407015","media":"Stock News","labels":["policyRegulatory","economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100407015?lang=en_us&edition=fundamental","pubTime":"2026-06-23 11:46","pubTimestamp":1782186399,"startTime":"0","endTime":"0","summary":"Shares in the innovative drug sector experienced a broad-based rally today.At the time of writing, SSY GROUP (02005) was up 6.93% at HK$2.16, KEYMED BIO-B (02162) gained 4.14% to HK$59.05, HENGRUI...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory,economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0455707207.USD","LU1969619763.USD","LU0561508036.HKD","LU2097828474.EUR","IE00B543WZ88.USD","BK1587","LU2097828557.USD","BK1161","09926","BK4585","LU0359201612.USD","01801","LU2097828631.EUR","LU0359202008.SGD","09939","LU0417516738.SGD","LU0502904849.HKD","02162","LU0540923850.HKD","LU2543165471.USD","06978","159992","01276","LU2476274720.SGD","IE00BPRC5H50.USD","LU0417516902.SGD","LU1961090484.USD","IE00B5MMRT66.SGD","VXUS","LU0348783233.USD","LU2488822045.USD","BK1583","LU2778985437.USD","LU2460026573.USD","BK1515","159938","LU2097828805.USD","LU0348767384.USD","LU2328871848.SGD","LU0348735423.USD","LU0359201885.HKD","LU1794554557.SGD","LU0634319403.HKD","LU1720050803.USD","LU0348784397.USD","02005","LU2399975544.HKD","LU1023057109.AUD","LU0348825331.USD","LU2476274308.USD","BK4588","LU0348827113.USD","BK1191","BK1574","LU2097828714.EUR","LU0348766576.USD","LU2242644610.SGD","LU0417516571.SGD","BK1589","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645004981","title":"European Drug Regulator Accepts Hengrui Pharma's Marketing Application for Revulutamide Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2645004981","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645004981?lang=en_us&edition=fundamental","pubTime":"2026-06-23 10:40","pubTimestamp":1782182438,"startTime":"0","endTime":"0","summary":"The European Medicines Agency accepted Jiangsu Hengrui Pharmaceuticals'  marketing application for revulutamide tablets, according to a Shanghai bourse filing on Tuesday.The drug is used in combination with androgen deprivation therapy for the treatment of adult male patients with prostate cancer.The Chinese pharmaceutical company's shares rose 2% during the morning trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EPV","LU0359201612.USD","LU2543165471.USD","LU0359201885.HKD","LU1023057109.AUD","01276","LU0359202008.SGD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196099833","title":"Movement Alert｜Hengrui Medicine Rises 3.73% in Regular Trading, First Self-Developed Innovative Drug Marketing Application Accepted by EMA","url":"https://stock-news.laohu8.com/highlight/detail?id=1196099833","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196099833?lang=en_us&edition=fundamental","pubTime":"2026-06-23 09:37","pubTimestamp":1782178654,"startTime":"0","endTime":"0","summary":"On June 23, Hengrui Medicine rose 3.73% in regular trading, trading at 57.45 HKD/share, with turnover of approximately 42.72 million HKD.On the news front, the company announced on June 22 that the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191996353","title":"Hengrui Pharma's Novel Drug Application for Rezvilutamide Accepted by European Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1191996353","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191996353?lang=en_us&edition=fundamental","pubTime":"2026-06-22 16:48","pubTimestamp":1782118137,"startTime":"0","endTime":"0","summary":"An application for marketing authorization of a new drug developed by Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (ASX: 600276) has been formally accepted for review by the European Medicines Agency...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2580892862.HKD","LU1969619763.USD","LU2097828474.EUR","BK4081","LU2580892789.USD","LU2097828557.USD","600276","LU2148510915.USD","EMA","LU0405327494.USD","LU2097828631.EUR","LU0359202008.SGD","LU1064131003.USD","BK0012","LU1328615791.USD","LU2543165471.USD","01276","BK0183","LU2495084118.USD","IPOS","LU1997245177.USD","BK0188","LU1997245094.SGD","BK0060","LU2488822045.USD","BK0239","BK0196","LU2097828805.USD","LU2328871848.SGD","LU1064130708.USD","LU1655091616.SGD","LU1255011170.USD","LU0359201885.HKD","LU1023057109.AUD","BK0028","LU1146622755.USD","LU1580142542.USD","LU0405327148.USD","LU1820825898.SGD","BK1191","LU1781817850.SGD","LU2289578879.USD","LU2097828714.EUR","LU1997244956.HKD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170586697","title":"AH Premium and Deviation Data for June 22","url":"https://stock-news.laohu8.com/highlight/detail?id=1170586697","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170586697?lang=en_us&edition=fundamental","pubTime":"2026-06-22 16:25","pubTimestamp":1782116720,"startTime":"0","endTime":"0","summary":"Data for the close on June 22 reveals the leading and lagging stocks in terms of AH share premium rates.The three stocks with the highest AH premium rates were NE ELECTRIC (HKG: 00042), ZHEJIANG...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0469268626.HKD","LU2399975544.HKD","LU0791591158.USD","BK1521","01108","03750","IE00BGHQDM52.EUR","03296","LU1244550577.SGD","LU0052750758.USD","LU0163747925.USD","03268","00956","BK1171","BK1501","IE00BVYPNQ40.USD","LU0588546209.SGD","LU0348825331.USD","BK1105","LU0449515922.USD","LU0880133367.SGD","LU0164880469.USD","LU0672654166.SGD","LU2039709279.SGD","01033","LU0231483743.USD","LU0348767384.USD","BK1140","IE0008369823.USD","IE00BF5LJ272.USD","02009","BK1551","IE0008368742.USD","LU0531970944.HKD","LU1303224171.USD","02208","BK1185","LU0029875118.USD","LU0359201885.HKD","IE00BMCWC346.EUR","LU0456827905.SGD","IE00B5MMRT66.SGD","LU0106959298.USD","LU1226287529.USD","LU2125910500.SGD","LU1808992512.USD","IE00B031J352.USD","03328","LU0979878070.USD","SG9999006597.SGD","BK1191","LU2778985437.USD","LU0648948544.HKD","BK1530","BK1546","06031","LU0823426308.USD","LU1880383440.USD","LU2045819591.USD","LU0326950275.SGD","LU0348814723.USD","BK1560","IE0034224299.USD","LU0054450605.USD","LU1831875114.USD","00895","HK0000352291.HKD","LU0456846285.SGD","LU0320764755.SGD","BK1147","BK1202","00991","IE00BYV24P56.USD","LU0488056044.USD","LU1244550221.USD","SG9999011746.SGD","BK1503","LU0048580855.USD","03968","LU0128522157.USD","IE00BZ08YS42.EUR","LU0384037296.USD","LU0449509016.USD","LU1224709979.USD","BK1258","BK1229","HK0001040168.HKD","01057","LU1115378108.SGD","LU0149534421.HKD","LU0320764599.SGD","BK1558","HK0000352382.USD","LU2294711473.HKD","02691","LU0918141887.USD","BK1564","LU0516422440.USD","BK1110","BK1537","BK1594","LU0593848301.USD","LU1960683339.HKD","LU0173614495.USD","LU0890818403.SGD","LU1366334578.USD","BK1223","LU1244550494.USD","BK1116","01276","LU0214875030.USD","LU0348735423.USD","BK1237","00588","BK1610","LU0543330483.HKD","LU1152091168.USD","BK1231","01081","LU0314109678.HKD","LU1813983027.USD","LU0051755006.USD","LU0797268264.HKD","LU1770034418.SGD","LU0228367735.SGD","LU0327786744.USD","LU0918141705.HKD","LU1282649067.USD","LU0516423091.SGD","LU1366334651.USD","02476","BK1154","LU0516422952.EUR","LU0502904849.HKD","LU0823426480.USD","IE00B3M56506.USD","01072","IE00B543WZ88.USD","LU1282648689.USD","LU0370786039.SGD","LU2476274308.USD","IE00BVYPNP33.GBP","LU0348766576.USD","BK1193","BK1563","HK0000252160.HKD","LU0307460666.USD","03143","IE00B29SXG58.USD","LU1046422090.SGD","LU0516423174.USD","BK1163","BK1526","BK1141","00916","BK1240","01528","02338","BK1125","BK1522","HK0001040143.USD","LU0417516738.SGD","LU0572944931.SGD","00042","LU1242518931.SGD","SG9999014674.SGD","LU1688375341.USD","LU0348788117.USD","LU0463099449.HKD","LU0117841782.USD","BK1554","LU0516422366.SGD","LU1023057109.AUD","LU0455707207.USD","LU1481107354.HKD","01330","SG9999004220.SGD","HK0000500386.USD","LU0067412154.USD","LU1282649810.SGD","BK1583","LU0607220059.USD","LU0634319403.HKD","LU1961090484.USD","LU0431992006.USD","LU0561508036.HKD","BK1552","LU1794554557.SGD","LU0708995583.HKD","LU2543165471.USD","IE00BZ08YR35.GBP","SG9999001226.SGD","LU1152091754.HKD","02218","LU0229945570.USD","LU0149721374.USD","06613","LU0244354667.USD","LU1105468828.SGD","BK1205","LU0348816934.USD","LU0737861699.HKD","SG9999002828.SGD","LU0348827113.USD","LU0823040885.USD","LU0640798160.USD","SG9999002463.SGD","LU1242518857.USD","IE00B031HY20.USD","LU0287142896.SGD","LU0359202008.SGD","LU0791590937.USD","LU0589944569.HKD","LU1880383366.USD","SG9999001093.SGD","LU1719994722.HKD","LU1993786604.SGD","LU1720050803.USD","LU0862451753.SGD","LU0543330566.HKD","LU0540923850.HKD","03678","01812","BK1166","LU0501845795.SGD","LU1251922891.USD","02359","BK1170","BK1562","LU0072913022.USD","BK1135","EWH","IE0031814852.USD","LU1675838814.USD","LU0254981946.USD","BK1507","IE00BPRC5H50.USD","LU1328277881.USD","BK1576","LU0359201612.USD","BK1514","LU0417516902.SGD","00995","02768","LU2476274720.SGD","159982","LU0348805143.USD","03986","399300","BK1567","LU1008478684.HKD","HK0000252152.HKD","BK1149","LU0315179316.USD","LU1807302812.USD","IE00BZ08YT58.USD","LU1282649141.HKD","LU1188198961.HKD","01349","LU2226246903.HKD","BK1144","LU1211504680.USD","BK1513","LU0868486357.SGD","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135717515","title":"Movement Alert｜Hengrui Medicine Falls 3.02% in Regular Trading, Broad Pharma Sector Sell-Off Amid Geopolitical Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=1135717515","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135717515?lang=en_us&edition=fundamental","pubTime":"2026-06-22 10:30","pubTimestamp":1782095402,"startTime":"0","endTime":"0","summary":"On June 22, Hengrui Medicine (01276.HK) declined 3.02% in regular trading, trading at HK$52.95/share, with turnover of HK$66.36 million. The decline came amid a broad sell-off across the Hong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137910385","title":"AH Share Premium and Deviation Rankings as of June 18th","url":"https://stock-news.laohu8.com/highlight/detail?id=1137910385","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137910385?lang=en_us&edition=fundamental","pubTime":"2026-06-18 16:24","pubTimestamp":1781771086,"startTime":"0","endTime":"0","summary":"As of the market close on June 18th, the top three stocks with the highest AH share premium rates were NE ELECTRIC (HKG: 00042), ZHEJIANG SHIBAO (HKG: 01057), and SINOPEC SSC (HKG: 01033), with...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01330","LU0359201612.USD","LU0417516902.SGD","00588","IE00B543WZ88.USD","LU0449515922.USD","IE0031814852.USD","LU0543330566.HKD","LU1813983027.USD","LU0128522157.USD","00719","LU0501845795.SGD","IE00BVYPNQ40.USD","LU1770034418.SGD","IE00BF5LJ272.USD","LU1366334651.USD","BK1568","LU1251922891.USD","LU1244550494.USD","BK1191","LU0531970944.HKD","03328","LU0307460666.USD","LU0117841782.USD","IE00B5MMRT66.SGD","LU1303224171.USD","BK1171","LU1152091168.USD","BK1231","01081","IE00BGHQDM52.EUR","LU0214875030.USD","LU0287142896.SGD","LU0320764755.SGD","LU0327786744.USD","LU0456846285.SGD","LU1807302812.USD","LU1880383440.USD","LU2399975544.HKD","IE00B031HY20.USD","LU0348816934.USD","BK1183","LU0791591158.USD","LU0229945570.USD","LU1880383366.USD","LU2125910500.SGD","SG9999014674.SGD","LU1282648689.USD","01033","BK1521","IE00BYV24P56.USD","LU0589944569.HKD","IE00B3M56506.USD","LU0823040885.USD","BK1202","LU0607220059.USD","LU0543330483.HKD","LU1244550221.USD","LU1008478684.HKD","BK1558","02208","BK1105","01812","BK1546","LU2476274720.SGD","LU1282649067.USD","BK1564","LU0561508036.HKD","IE0008368742.USD","LU0640798160.USD","LU2226246903.HKD","LU1188198961.HKD","LU0648948544.HKD","LU1282649810.SGD","BK1163","LU1328277881.USD","LU0149534421.HKD","LU1023057109.AUD","LU0359201885.HKD","IE00BZ08YT58.USD","LU0572944931.SGD","03678","SG9999004220.SGD","03750","01057","BK1141","LU2039709279.SGD","LU1366334578.USD","LU0348767384.USD","03143","LU2045819591.USD","SG9999001226.SGD","LU0488056044.USD","02465","LU0348805143.USD","LU2294711473.HKD","03986","LU1046422090.SGD","EWH","399300","LU1675838814.USD","LU0315179316.USD","LU0449509016.USD","SG9999002828.SGD","LU0359202008.SGD","LU1808992512.USD","BK1610","LU0862451753.SGD","LU0791590937.USD","LU1242518857.USD","LU0823426480.USD","IE00BZ08YR35.GBP","LU0469268626.HKD","LU1226287529.USD","BK1110","LU1224709979.USD","02359","LU0918141705.HKD","LU0417516738.SGD","SG9999011746.SGD","BK1523","BK1506","IE0008369823.USD","IE00BMCWC346.EUR","LU0516423091.SGD","BK1140","LU0588546209.SGD","LU0231483743.USD","LU0979878070.USD","LU1960683339.HKD","SG9999002463.SGD","LU0737861699.HKD","LU0054450605.USD","BK1503","LU0244354667.USD","BK1576","LU0228367735.SGD","LU2778985437.USD","BK1225","BK1170","01276","LU1242518931.SGD","02476","BK1154","BK1507","LU0708995583.HKD","LU0502904849.HKD","LU0672654166.SGD","BK1594","01108","06031","LU1961090484.USD","LU0348735423.USD","LU0516423174.USD","01053","HK0000500386.USD","LU2476274308.USD","BK1166","LU0348814723.USD","LU1794554557.SGD","02338","IE00BPRC5H50.USD","IE0034224299.USD","BK1513","BK1149","BK1560","BK1562","LU0516422952.EUR","00991","LU0890818403.SGD","LU0823426308.USD","LU0106959298.USD","02218","03968","LU0072913022.USD","LU0164880469.USD","LU0384037296.USD","LU1152091754.HKD","SG9999006597.SGD","LU0348766576.USD","LU2543165471.USD","LU0173614495.USD","LU0163747925.USD","LU0370786039.SGD","LU0540923850.HKD","BK1551","LU0067412154.USD","LU1244550577.SGD","LU1688375341.USD","LU0516422366.SGD","BK1537","LU0797268264.HKD","LU2242644610.SGD","HK0001040143.USD","HK0000252160.HKD","BK1240","02691","IE00BVYPNP33.GBP","HK0000352291.HKD","LU0051755006.USD","BK1526","02768","BK1554","LU1719994722.HKD","IE00BZ08YS42.EUR","BK1530","LU0455707207.USD","LU0326950275.SGD","LU0463099449.HKD","BK1522","HK0000352382.USD","LU1105468828.SGD","159982","00470","LU0314109678.HKD","LU0880133367.SGD","BK1515","LU0868486357.SGD","BK1125","LU0348827113.USD","00916","BK1205","LU0149721374.USD","LU0593848301.USD","LU1481107354.HKD","BK1583","LU0254981946.USD","LU1993786604.SGD","LU0029875118.USD","IE00B031J352.USD","03296","LU0918141887.USD","LU0348825331.USD","BK1197","HK0001040168.HKD","BK1514","LU1211504680.USD","BK1147","LU0320764599.SGD","LU0634319403.HKD","BK1116","LU1282649141.HKD","00042","BK1237","BK1223","06869","LU0431992006.USD","HK0000252152.HKD","02607","LU0048580855.USD","LU1720050803.USD","LU0052750758.USD","00956","BK1193","IE00B29SXG58.USD","LU0456827905.SGD","SG9999001093.SGD","LU1831875114.USD","LU0516422440.USD","LU1115378108.SGD","LU0348788117.USD","BK1144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142436116","title":"Movement Alert｜Hengrui Medicine Rises 3.02% in Regular Trading, Multiple Drug Approvals and Institutional Buying Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1142436116","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142436116?lang=en_us&edition=fundamental","pubTime":"2026-06-18 10:23","pubTimestamp":1781749437,"startTime":"0","endTime":"0","summary":"On June 18, Hengrui Medicine rose 3.02% in regular trading, trading at 54.7 HKD/share, with turnover of approximately 46.74 million HKD. The rally was driven by a convergence of positive catalysts...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147136836","title":"Schroders Increases Stake in Hengrui Pharma by 948,800 Shares at HK$54.54 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1147136836","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147136836?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697627,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, Schroders increased its holding in Hengrui Pharma (01276) by 948,800 shares on June 12.The purchase price was approximately HK$54.54...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2580892862.HKD","LU1997245177.USD","LU2495084118.USD","LU1997244956.HKD","LU2543165471.USD","LU1820825898.SGD","LU0359201612.USD","EWH","LU1023057109.AUD","LU0405327494.USD","BK0028","LU1580142542.USD","LU2097828474.EUR","LU2328871848.SGD","LU2097828714.EUR","LU1328615791.USD","LU1255011170.USD","LU0359202008.SGD","LU0405327148.USD","LU1064131003.USD","LU2097828631.EUR","BK0188","LU2488822045.USD","LU1064130708.USD","LU1655091616.SGD","BK1191","BK0183","LU0359201885.HKD","LU2097828557.USD","LU2148510915.USD","LU1997245094.SGD","01276","BK0012","BK0196","LU2097828805.USD","BK0060","LU1781817850.SGD","BK0239","LU2580892789.USD","600276","LU1969619763.USD","LU1146622755.USD","LU2289578879.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176445493","title":"Hengrui Pharma repurchases 120,000 A shares for ESOP; treasury stock rises to 8.31 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1176445493","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176445493?lang=en_us&edition=fundamental","pubTime":"2026-06-17 17:07","pubTimestamp":1781687221,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) disclosed a share buyback on 17 June 2026, aimed at its A-share Employee Stock Ownership Schemes (ESOP). • Transaction details: 120,000 A...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151105639","title":"Hengrui Pharma Executes Share Buyback on June 17","url":"https://stock-news.laohu8.com/highlight/detail?id=1151105639","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151105639?lang=en_us&edition=fundamental","pubTime":"2026-06-17 16:58","pubTimestamp":1781686711,"startTime":"0","endTime":"0","summary":"On June 17, Hengrui Pharma (01276) carried out a share repurchase transaction.The company invested approximately 5.6245 million yuan to buy back 120,000 of its A-shares.The repurchase price ranged between 46.85 yuan and 46.88 yuan per share.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","LU1997245094.SGD","LU0359202008.SGD","BK0188","LU1328615791.USD","LU1064130708.USD","LU1997245177.USD","LU0359201612.USD","LU2580892862.HKD","BK0060","LU0405327148.USD","LU2289578879.USD","LU2488822045.USD","600276","BK0183","LU1023057109.AUD","LU1064131003.USD","LU1255011170.USD","LU1781817850.SGD","LU2580892789.USD","LU2097828805.USD","LU1820825898.SGD","BK0196","LU1997244956.HKD","LU1146622755.USD","BK1191","01276","LU2097828631.EUR","BK0028","399300","LU1655091616.SGD","LU2495084118.USD","BK0239","BK0012","LU2328871848.SGD","LU0359201885.HKD","LU2097828474.EUR","159982","LU0405327494.USD","LU1580142542.USD","LU2148510915.USD","LU2097828557.USD","LU1969619763.USD","LU2097828714.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644790190","title":"China Greenlights Clinical Trials for Two Hengrui Pharma Drugs, Approves Another Indication for Breast Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2644790190","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644790190?lang=en_us&edition=fundamental","pubTime":"2026-06-17 12:42","pubTimestamp":1781671346,"startTime":"0","endTime":"0","summary":"China's drug regulator approved clinical trials for Jiangsu Hengrui Pharmaceuticals'  SHR-6914 injection and HRS-7525 tablets, according to separate filings with the Shanghai bourse on Wednesday.The SHR-6914 injection, produced by subsidiary Suzhou Shengdiya Biopharmaceutical, is indicated for tumors related to prostate cancer.Hengrui's HRS-7525 tablets are indicated for solid tumors.The regulator also approved another indication for its dalpiciclib isethionate tablets for early-stage breast cancer with high risk of recurrence, and are hormone receptor-positive and human epidermal growth factor receptor 2-negative.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1328615791.USD","BK0188","LU2495084118.USD","LU2543165471.USD","BK1191","600276","LU0359201612.USD","LU1997244956.HKD","LU2488822045.USD","LU1655091616.SGD","LU1064131003.USD","LU2328871848.SGD","LU1997245094.SGD","LU2097828631.EUR","BK0183","BK0196","LU2097828557.USD","LU1146622755.USD","LU0359202008.SGD","BK0028","LU0405327148.USD","BK0012","LU0359201885.HKD","LU1023057109.AUD","LU2580892862.HKD","LU1781817850.SGD","LU1255011170.USD","LU1580142542.USD","LU2097828474.EUR","LU2148510915.USD","BK0060","LU2580892789.USD","LU0405327494.USD","LU2289578879.USD","LU1064130708.USD","BK0239","LU1820825898.SGD","LU1969619763.USD","LU1997245177.USD","01276","LU2097828714.EUR","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643775070","title":"Jiangsu Hengrui Pharmaceuticals -  Received Notice From Nmpa New Indication for Dalpiciclib Isethionate Tablets, Cdk4/6 Inhibitor Approved","url":"https://stock-news.laohu8.com/highlight/detail?id=2643775070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643775070?lang=en_us&edition=fundamental","pubTime":"2026-06-16 21:32","pubTimestamp":1781616752,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nFWN42O0JG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1997245177.USD","BK0183","BK0188","LU2580892789.USD","LU1064130708.USD","BK0239","LU1146622755.USD","01276","LU0405327148.USD","LU2495084118.USD","LU0359202008.SGD","LU1655091616.SGD","LU0359201885.HKD","LU0359201612.USD","LU1023057109.AUD","BK0028","LU2543165471.USD","BK0196","LU2097828474.EUR","BK1191","BK0060","LU1781817850.SGD","LU2580892862.HKD","LU2488822045.USD","LU2097828714.EUR","LU1820825898.SGD","LU2097828557.USD","LU2328871848.SGD","LU1064131003.USD","LU2097828631.EUR","LU1969619763.USD","600276","LU1255011170.USD","LU2148510915.USD","LU1580142542.USD","LU2289578879.USD","LU1328615791.USD","LU0405327494.USD","BK0012","LU1997244956.HKD","LU1997245094.SGD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}